RUNX1/ETO tetramerization-IN-1, CAS [[88755-39-9]]

Produktübersicht

• Artikelname: RUNX1/ETO tetramerization-IN-1, CAS [[88755-39-9]]
• Artikelnummer: MCE-HY-151411
• Hersteller Artikelnummer: HY-151411
• Alternativnummer: MCE-HY-151411-25MG,MCE-HY-151411-5MG,MCE-HY-151411-50MG,MCE-HY-151411-10MMX1ML,MCE-HY-151411-10MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

RUNX1/ETO tetramerization-IN-1 is a small-molecule inhibitor of RUNX1/ETO tetramerization, exhibits anti-leukemic effect. RUNX1/ETO tetramerization-IN-1 specifically targets to NHR2 of RUNX1/ETO (EC50=0.25 µM), restores gene expression down-regulated by RUNX1/ETO. RUNX1/ETO tetramerization-IN-1 inhibits the proliferation of RUNX1/ETO-depending SKNO-1 cells, and reduces the RUNX1/ETO-related tumor growth in a mouse model[1][2][3].

Produkteigenschaften

• Molekulargewicht: 342.30
• Reinheit: 99.36
• CAS Nummer: [88755-39-9]
• Formel: C18H14O7
• Target-Kategorie: RUNX

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound